The exploitation of cerebrospinal fluid-derived circulating DNA as liquid biopsy promises a more accurate, effective and less invasive approach in unmasking the molecular characteristics of brain tumors.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1PzZuCR
No comments:
Post a Comment